See the DrugPatentWatch profile for Novolin
What is Novolin 70/30, and what is it used for?
Novolin 70/30 is a premixed insulin product that contains two insulin types: 70% intermediate-acting insulin and 30% short-acting insulin. It’s used to help control blood sugar in people with diabetes who need insulin therapy.
Because it’s a premixed insulin, dosing is typically timed around meals and follows a prescriber’s instructions.
How is Novolin 70/30 usually taken?
Novolin 70/30 is injected under the skin (subcutaneous). The exact dose and timing depend on your blood sugar readings, meal schedule, and your clinician’s plan. Since it mixes intermediate- and short-acting insulin, it’s commonly used when a person needs both “meal coverage” and longerer control between meals.
If you tell me the country you’re in and whether you mean the vial or FlexPen/pen format, I can help you match typical labeling instructions more closely.
When does Novolin 70/30 start working, and how long does it last?
Premixed insulins like 70/30 are designed to cover both:
- insulin action around the time you eat (from the short-acting component), and
- continued glucose control afterward (from the intermediate-acting component).
Exact onset and duration can vary by person and formulation. Your package insert will list specific expected timing.
What side effects should people watch for?
The most important risk with insulin is hypoglycemia (low blood sugar). Other possible side effects can include injection-site reactions and weight gain. If you’re experiencing frequent lows, high readings despite dosing, or symptoms of severe hypoglycemia, you should contact a clinician promptly.
How is Novolin 70/30 different from other insulin mixes (like 75/25)?
The “70/30” in Novolin 70/30 refers to the percentage of intermediate-acting versus short-acting insulin in the mix. Other premixes (such as 75/25) change those proportions, which can affect the timing of glucose control and may change dosing patterns.
Is Novolin 70/30 the same as “NPH 70/30” or “Humulin 70/30”?
Products with the same mix ratio (70/30) are conceptually similar (same percentages of insulin types), but they may differ by brand, manufacturer, and device format. If you share the exact label text (and strength/unit), I can help you interpret what you have.
DrugPatentWatch angle: why it may matter
If you’re looking up Novolin 70/30 for patent or exclusivity reasons (for example, biosimilar/generic availability), DrugPatentWatch.com can be a useful reference point for insulin product patent status and related filings.
You can search there for the specific product name and manufacturer: https://www.drugpatentwatch.com/
Quick clarification so I answer the right thing
When you say “Novolin 70 30,” what do you need?
- dosing/how to take it?
- onset/duration?
- side effects?
- how it compares to another insulin mix (like 75/25)?
- product identification (vial vs pen, concentration/strength)?
Reply with the exact wording from your box or label (including strength, like U-100), and your country, and I’ll tailor the answer.